Spencer Fane attorney Brian Malkin will co-lead a virtual DC Bar program, FDA for IP Lawyers, on May 28.
For this CLE, Brian and Sara Koblitz (Director, Hyman, Phelps & McNamara PC) will examine how regulatory considerations shape patent strategy, compliance, and risk management for products governed by the U.S. Food and Drug Administration (FDA). Topics will include the impact of FDA oversight on intellectual property safeguards, common challenges attorneys face in this sphere, and strategies for meeting regulatory compliance.
At Spencer Fane, Brian streamlines processes for clients navigating the complex intersection of patent law and food and drug law, leveraging unique public and private sector experience, in-depth creative and strategic analysis, and advanced negotiation tactics to meet and exceed stakeholder expectations. This life sciences skill set is evident across Brian’s focus areas, which include U.S. FDA and patent litigation for FDA-regulated manufacturers and pharmacies, patent prosecution for life sciences companies, and robust regulatory counsel for products spanning human and animal drugs and biologics, medical devices, foods and dietary supplements, tobacco products, and cosmetics.
Register for Brian’s webinar here. Please note, early bird registration ends on May 22.